Cell No. : Cell Name
RCB1316 : CTB-1 update : 2024/01/17 |
||||
Comment | Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis. | |||
Comment from the depositor | ||||
Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. | |||
Remarks | ||||
Order Form | Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)   | |||
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp). | ||||
Basic information | Depositor | Miyazawa, Keisuke | ||
Originator | Miyazawa, Keisuke & Uchida, Yoshiko | |||
Year of deposit | 1997 | |||
Animal | _human < Mammals | |||
Genus | Homo | |||
Species | sapiens | |||
Race | Japanese | |||
Gender | Male | |||
Age at sampling | 70 years | |||
Tissue | lymph node, B-lymphoma | |||
Disease name | non-Hodgkin's lymphoma | |||
Metastatic ability | Yes | |||
Classification | cancer | |||
Year of origin | 1994 | Lifespan | infinite | |
Morphology | lymphocyte-like | |||
Cellosaurus(Expasy) | CVCL_1149 | |||
Medium | Medium List | Culture type | Suspension cells | |
Culture method | 浮遊細胞の培養に関する一般的な注意(Japanese) | |||
Culture medium | RPMI1640 + 10% FBS | |||
Antibiotics | Free | Passage method | dilution | Culture information | Passage ratio | 1 : 10 split |
SC frequency | Subculture : 2 times/week | |||
Temperature | 37 ℃ | |||
CO2 concentration | 5 % | |||
Freeze medium | Medium + 10% DMSO | |||
Freezing method | Slow freezing | |||
Mycoplasma | (-) | |||
Virus (HIV) | LT 400 | |||
Virus (HTLV-1) | (-) | |||
Virus (EBV) | (+) | |||
Isozyme | LD, NP | |||
Chromosome mode | 47-49(50) : 47(1),48(48),49(1) | |||
STR(human) | OK | |||
Reference information | Reference | 1 | ||
User's Publication | 1 | |||